In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Taiho Oncology, Inc. announced today presentations at the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI), to be held ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...

Each year, over 1.2 million Americans receive a cancer diagnosis, a journey that can be both overwhelming and daunting.

New book exposes cancer diet myths, debunks misconceptions about fasting, sugar, and dairy, and advocates evidence-based nutrition to support patients through oncology treatment ...

Fintel reports that on January 7, 2025, TD Cowen initiated coverage of CG Oncology (NasdaqGS:CGON) with a Buy recommendation.